Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

Humber River Health Renames Wilson Site Hennick Humber Hospital Following Transformational $50 Million Gift

Humber River Health has announced a significant transformation with the renaming of its Wilson site to Hennick Humber Hospital, following a $50 million philanthropic gift from Jay and Barbara Hennick. This donation, one of the largest ever made to a community hospital in Canada, aims to enhance patient care, innovation, research, and education at the facility. The Hennick family’s commitment to advancing healthcare aligns with Humber River Health’s reputation as a leader in digital health and patient-centered care, which has set benchmarks in safety and operational efficiency.

The implications of this investment are profound. Humber River Health has established itself as North America’s first fully digital hospital, integrating advanced technologies such as real-time data analytics and robotic-assisted surgery. These innovations have not only improved patient outcomes—evidenced by surgical wait times being the lowest in the Greater Toronto Area—but also enhanced operational efficiencies, with safety metrics exceeding provincial and national averages for seven consecutive years. The Hennick family’s support will enable the hospital to scale these initiatives, fostering the development of new models of care that integrate hospital services with community health resources.

This shift marks a pivotal moment for healthcare innovation in the region. The Hennick Humber Hospital’s focus on breakthrough technologies and advanced clinical programs will likely influence future funding strategies and research priorities within the aging biology and longevity sectors. As hospitals like Humber leverage philanthropic investments to advance their capabilities, it may accelerate timelines for the adoption of cutting-edge therapies and patient care models, ultimately enhancing healthspan and longevity outcomes for diverse populations.

Source: globenewswire.com